Keyphrases
Patients with Breast Cancer
100%
Gut Microbiota
100%
Tamoxifen Therapy
100%
Endoxifen
100%
Breast Cancer Patients
42%
Gut Microbiota Composition
42%
Estrogen Receptor-positive
42%
HER2 Breast Cancer
42%
Metabolism
14%
Multiple Comparisons
14%
Blood Samples
14%
Prevotella
14%
Plasma Parameters
14%
Fecal Samples
14%
Microbial Composition
14%
Microbial Diversity
14%
Community Structure
14%
Microbial Community Structure
14%
Microbial Abundance
14%
Prospective Observational Study
14%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
14%
Potential Interaction
14%
Therapeutic Outcome
14%
Active Metabolite
14%
Human Epidermal Growth Factor Receptor 2-negative
14%
Estrogen Receptor-positive Breast Cancer
14%
Treatment-seeking Sample
14%
Gene-rich Regions
14%
Comprehensive Research
14%
16S rRNA Gene Amplicon Sequencing
14%
Blautia
14%
Microbial Taxa
14%
Hypervariable
14%
INIS
patients
100%
cancer
100%
therapy
100%
tamoxifen
100%
breasts
100%
levels
55%
receptors
55%
correlations
44%
estrogens
44%
communities
22%
plasma
22%
humans
11%
comparative evaluations
11%
blood
11%
genes
11%
mass spectrometry
11%
liquid column chromatography
11%
metabolites
11%
metabolism
11%
interactions
11%
streptococcus
11%
growth factors
11%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Intestine Flora
100%
Tamoxifen
100%
Endoxifen
77%
Estrogen Receptor
33%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
22%
Epidermal Growth Factor Receptor 2
11%
Gamma Urogastrone
11%
Observational Study
11%
Active Metabolite
11%
Streptococcus
11%
RNA 16S
11%
Estrogen Receptor Positive Breast Cancer
11%
Prevotella
11%
Blautia
11%
Immunology and Microbiology
Intestine Flora
100%
Microbial Diversity
25%
Blood Level
12%
Blood Plasma
12%
Metabolite
12%
Gamma Urogastrone
12%
Liquid Chromatography Mass Spectrometry
12%
Streptococcus
12%
Taxon
12%
Prevotella
12%
Amplicon Sequencing
12%
Blautia
12%